ATE244889T1 - Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen - Google Patents
Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationenInfo
- Publication number
- ATE244889T1 ATE244889T1 AT99906769T AT99906769T ATE244889T1 AT E244889 T1 ATE244889 T1 AT E244889T1 AT 99906769 T AT99906769 T AT 99906769T AT 99906769 T AT99906769 T AT 99906769T AT E244889 T1 ATE244889 T1 AT E244889T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- amount
- determining
- sample
- disease
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2695798A | 1998-02-20 | 1998-02-20 | |
US15105798A | 1998-09-10 | 1998-09-10 | |
PCT/US1999/002580 WO1999042829A1 (en) | 1998-02-20 | 1999-02-05 | Assay for specific strains of multiple disease related conformations of a protein |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE244889T1 true ATE244889T1 (de) | 2003-07-15 |
Family
ID=26701861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99906769T ATE244889T1 (de) | 1998-02-20 | 1999-02-05 | Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1057022B1 (de) |
JP (1) | JP2003519357A (de) |
KR (1) | KR20010041135A (de) |
AT (1) | ATE244889T1 (de) |
AU (1) | AU753331B2 (de) |
BR (1) | BR9908059A (de) |
CA (1) | CA2318477A1 (de) |
DE (2) | DE69909442T2 (de) |
ES (1) | ES2203073T3 (de) |
WO (1) | WO1999042829A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620629B1 (en) | 1997-02-21 | 2003-09-16 | The Regents Of The University Of California | Method for detecting prions |
US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
US6221614B1 (en) | 1997-02-21 | 2001-04-24 | The Regents Of The University Of California | Removal of prions from blood, plasma and other liquids |
US7041807B1 (en) | 1999-06-23 | 2006-05-09 | Caprion Pharmaceuticals, Inc. | Antibodies to a YYX epitope of a mammalian prion protein |
KR20010112840A (ko) * | 2000-06-15 | 2001-12-22 | 김유삼 | 기능성 단백질의 패턴분석을 이용한 진단 시스템 |
US6537548B1 (en) * | 2000-07-27 | 2003-03-25 | The Regents Of The University Of California | Antibodies specific for ungulate PrP |
US6716589B2 (en) * | 2000-11-20 | 2004-04-06 | Alphabeta Ab | Discordant helix stabilization for prevention of amyloid formation |
AUPR293801A0 (en) * | 2001-02-07 | 2001-03-01 | Novapharm Research (Australia) Pty Ltd | Prion disinfection |
GB2376071A (en) * | 2001-05-31 | 2002-12-04 | Mini Agriculture & Fisheries | Method for typing a TSE strain |
JP2005504289A (ja) | 2001-09-20 | 2005-02-10 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | プリオンアッセイ用に調製された筋肉試料 |
US7052849B2 (en) | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
US20040072236A1 (en) | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
MX2007008497A (es) * | 2005-01-13 | 2007-09-14 | Novartis Vaccines & Diagnostic | Ensayos inmunosorbentes enlazados a enzimas usando reactivos de peptidos especificos de prion. |
US8293174B2 (en) | 2007-10-17 | 2012-10-23 | American Sterilizer Company | Prion deactivating composition and methods of using same |
JP5747444B2 (ja) * | 2010-04-27 | 2015-07-15 | パナソニックヘルスケア株式会社 | βアミロイドに関連する病的状態の診断補助方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806627A (en) * | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
AU4376093A (en) * | 1992-05-15 | 1993-12-13 | Instituto Nazionale Neurologico C. Besta | Soluble prion polypeptides, and methods for detecting and purifying thereof |
US5565186A (en) * | 1994-05-13 | 1996-10-15 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
US5757361A (en) * | 1996-03-20 | 1998-05-26 | International Business Machines Corporation | Method and apparatus in computer systems to selectively map tablet input devices using a virtual boundary |
US5891641A (en) * | 1997-02-21 | 1999-04-06 | The Regents Of The University Of California | Assay for disease related conformation of a protein |
US5977324A (en) * | 1998-02-20 | 1999-11-02 | The Regents Of The University Of California | Process for concentrating protein with disease-related conformation |
-
1999
- 1999-02-05 AU AU26602/99A patent/AU753331B2/en not_active Ceased
- 1999-02-05 EP EP99906769A patent/EP1057022B1/de not_active Expired - Lifetime
- 1999-02-05 DE DE69909442T patent/DE69909442T2/de not_active Expired - Fee Related
- 1999-02-05 BR BR9908059-1A patent/BR9908059A/pt not_active IP Right Cessation
- 1999-02-05 KR KR1020007009182A patent/KR20010041135A/ko not_active Application Discontinuation
- 1999-02-05 ES ES99906769T patent/ES2203073T3/es not_active Expired - Lifetime
- 1999-02-05 WO PCT/US1999/002580 patent/WO1999042829A1/en not_active Application Discontinuation
- 1999-02-05 DE DE1057022T patent/DE1057022T1/de active Pending
- 1999-02-05 AT AT99906769T patent/ATE244889T1/de not_active IP Right Cessation
- 1999-02-05 JP JP2000532720A patent/JP2003519357A/ja active Pending
- 1999-02-05 CA CA002318477A patent/CA2318477A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE1057022T1 (de) | 2001-10-25 |
EP1057022B1 (de) | 2003-07-09 |
DE69909442D1 (de) | 2003-08-14 |
EP1057022A1 (de) | 2000-12-06 |
KR20010041135A (ko) | 2001-05-15 |
ES2203073T3 (es) | 2004-04-01 |
CA2318477A1 (en) | 1999-08-26 |
JP2003519357A (ja) | 2003-06-17 |
EP1057022A4 (de) | 2001-05-30 |
AU753331B2 (en) | 2002-10-17 |
AU2660299A (en) | 1999-09-06 |
DE69909442T2 (de) | 2004-04-22 |
WO1999042829A1 (en) | 1999-08-26 |
BR9908059A (pt) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE244889T1 (de) | Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen | |
Kokame et al. | FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay | |
Krishnaswamy et al. | The binding of factor Va to phospholipid vesicles. | |
Carmona et al. | A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay | |
Lenarcic et al. | Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D | |
Rehfeld et al. | Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples | |
ATE300051T1 (de) | Test zum nachweis von prionen-proteinen die in einer mit krankheit assoziierten konformationen vorliegen | |
Vaculova et al. | Chapter eight caspases: determination of their activities in apoptotic cells | |
ATE205884T1 (de) | Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie | |
Gomes et al. | A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca2+-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin | |
DE69029785D1 (de) | Kinetische Bestimmungsmethode für Endotoxin unter Verwendung von Limulus-Amoebocyten-Lysat und chromogenem Substrat | |
Yin et al. | Measurement of peptide binding to MHC class II molecules by fluorescence polarization | |
Hassoun et al. | Procollagen C-proteinase enhancer 1 (PCPE-1) as a plasma marker of muscle and liver fibrosis in mice | |
ATE343597T1 (de) | Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie | |
DE60037864D1 (de) | Enzymhemmungsimmunverfahren | |
Dukhanina et al. | Spectral studies on the calcium-binding properties of Mts1 protein and its interaction with target protein | |
Bouman et al. | Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly women | |
Kumar et al. | The effect of elapsed time on cardiac troponin-T (cTnT) degradation and its relation to postmortem interval in cases of electrocution | |
Glover et al. | Supramolecular calsequestrin complex: Protein–protein interactions in chronic low‐frequency stimulated muscle, postnatal development and ageing | |
Santra et al. | Assaying collagenase activity by specific labeling of freshly generated N-termini with fluorescamine at mildly acidic pH | |
JP2003535103A (ja) | BoNT/B型のボツリヌス毒素により認識されるペプチド基質並びに前記毒素もしくは対応の阻害物質をアッセイ及び/もしくは検出する為のそれらの利用 | |
WO2002035238A8 (en) | Method of determining prion strain | |
Troeberg et al. | Analysis of TIMP expression and activity | |
Hu et al. | Chemical and Biochemical Strategies To Explore the Substrate Recognition of O‐GlcNAc‐Cycling Enzymes | |
Lundebye et al. | Improved quantification of stress proteins by western blotting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |